Matthew Labriola

11PUBLICATIONS
86CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSocial and community informaticsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Aug 23, 2024
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.

Laura S Graham, Nicholas C Henderson, Olesia Kellezi

|Jul 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.

Amanda Broderick, Elizabeth Pan, Jinju Li

|Apr 05, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.

Joseph J Park, Alec Chu, Jinju Li

|Feb 22, 2024
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.

Zeynep B Zengin, Nicholas C Henderson, Joseph J Park

Pageof 2

Frequent Collaborators

6 joint publications

Andrew J Armstrong

5 joint publications

Michael Thomas Schweizer

5 joint publications

Clara Hwang

5 joint publications

Tanya Dorff